Concurent Chemoradiotherapy in Head and Neck Cancers
NCT04780750
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
DRUG:
Docetaxel
Sponsor
Assiut University